Neuroblastoma Therapy
Study results from Shanghai Jiao Tong University, Department of Hematology-Oncology broaden understanding of neuroblastoma therapy
Published in Hospital Business Week, December 2nd, 2007
A report, 'Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma,' is newly published data in Pediatric Blood and Cancer. Researchers in Shanghai, People's Republic of China conducted a study "To determine whether neuroblastoma (NB) minimal residual disease (MRD) in bone marrow (BM) detected by flow cytometry could predict prognosis and whether tumor cell purging by CD34(+) cell selection prior to transplantation will impact on disease-free survival NB MRD in BM was evaluated by flow cytometry with CD45-FITC-/CD81-PE+/CD56-PECy5+ monoclonal antibodies cocktail....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Aethon Inc.
Aethon Appoints Joe Costa Vice President of Marketing - Affiliated Computer Services, Inc.
ACS Bolsters Technology Services to Hospitals With Addition of Bed Management Software Solution - Aging
New Research Shows Sharp Rise in Nursing Home Care Violations Under Private Equity Ownership - Aging
Online Shopping for Those with Disabilities and the Aging - Aktiv-Dry Llc
Aktiv-Dry Awarded Research Grant to Explore Inhalable siRNA Dry Powder Targeting RSV - Alvarado Hospital
Alvarado Hospital and California Nurses Association Reach Four-Year Agreement - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
